Navigating Changes in Patient Drug and Non-Drug Item Demands in Community Pharmacies Amidst the COVID-19 Pandemic

Changes in drug demand during COVID19

Authors

  • Eman R. Elayeh Biopharmaceutics and Clinical Pharmacy Department, School of Pharmacy, The University of Jordan, Amman, Jordan
  • Randa N. Haddadin Pharmaceutics and Pharmaceutical Technology Department, School of Pharmacy, The University of Jordan, Amman, Jordan https://orcid.org/0000-0002-1214-0129
  • Razan J. Dawud Biopharmaceutics and Clinical Pharmacy Department, School of Pharmacy, The University of Jordan, Amman, Jordan
  • Heba o. Alsinjlawi Biopharmaceutics and Clinical Pharmacy Department, School of Pharmacy, The University of Jordan, Amman, Jordan
  • Rahaf k. Zidan Sama Pharma Pharmacy, Amman, Jordan

DOI:

https://doi.org/10.35516/jjps.v17i1.1426

Keywords:

Jordan, COVID-19, pharmacists, community pharmacy, drug demand, self-medication

Abstract

During the COVID-19 pandemic, healthcare systems worldwide faced unprecedented challenges, with pharmacists playing a crucial role on the frontlines. They encountered a surge in patient requests for drugs and non-drug items related to the treatment and prevention of the disease. This cross-sectional survey aimed to assess changes in demand for selected drugs and non-drug items from the perspective of pharmacists in Jordan in the period from March to June 2021, and to explore the factors influencing this demand. An online questionnaire targeting pharmacists working in community pharmacies was developed, validated, and disseminated using social media (e.g., WhatsApp, Facebook, and Messenger). The study collected 390 responses from pharmacists working in community pharmacies. The findings revealed significant increases in demand for prescription drugs such as antibiotics (97.4%), antithrombotics (84.1%), and antivirals (66.2%), often without prescriptions. Non-prescription items, specifically minerals and vitamins, were highly sought after (100%). Demand also rose for non-drug items such as thermometers (89.0%), oximeters (85.1%) and oxygen concentrators (68.2%). Changes in drug requirements were consistent across Jordan’s districts. However, an association was observed between the increase in demand for antivirals and herbal supplements and chain pharmacies (p-value 0.037 and p-value <0.005, respectively). In conclusion, COVID-19 led to a significant upsurge in the demand for pharmaceutical products and devices, placing immense pressure on community pharmacies. The public's reaction to the pandemic, to combat and manage the disease, was consistent across Jordan, regardless of social, financial, and spatial differences among the population. The study highlights the importance of adequately preparing and educating pharmacists to provide accurate information and counseling to patients in such circumstances. Therefore, health authorities must ensure that pharmacists have access to the latest treatments and management protocols and provide clear guidance on using home treatment devices to the public.

References

Ferrer R. COVID-19 Pandemic: the greatest challenge in the history of critical care. Med Intensiva. 2020; 44(6):323; doi: 10.1016/J.MEDIN.2020.04.002. DOI: https://doi.org/10.1016/j.medine.2020.04.005

Gadhiya KP, Hansrivijit P, Gangireddy M, et al. Clinical characteristics of hospitalised patients with COVID-19 and the impact on mortality: a single-network, retrospective cohort study from Pennsylvania state. BMJ Open. 2021; 11(4):e042549; doi: 10.1136/BMJOPEN-2020-042549. DOI: https://doi.org/10.1136/bmjopen-2020-042549

WHO. Episode #36 - Safe Care at Home. 2021. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/media-resources/science-in-5/episode-36---safe-care-at-home?gclid=Cj0KCQjwk4yGBhDQARIsACGfAetc5qSaG7lDmV-yVkttTZk6QvWi2OJpPT28PHJnxGbpe0nBfYWtJfAaAnWZEALw_wcB [Last accessed: 6/12/2021].

Elayeh E, Aleidi SM, Ya’acoub R, et al. Before and after case reporting: A comparison of the knowledge, attitude and practices of the Jordanian population towards COVID-19. PLoS One. 2020; 15(10 October):e0240780; doi: 10.1371/journal.pone.0240780.

Quispe-Cañari JF, Fidel-Rosales E, Manrique D, et al. Self-medication practices during the COVID-19 pandemic among the adult population in Peru: A cross-sectional survey. Saudi Pharm J. 2021; 29(1):1–11; doi: 10.1016/j.jsps.2020.12.001. DOI: https://doi.org/10.1016/j.jsps.2020.12.001

Sadio AJ, Gbeasor-Komlanvi FA, Konu RY, et al. Assessment of self-medication practices in the context of the COVID-19 outbreak in Togo. BMC Public Health. 2021; 21(1):1–9; doi: 10.1186/s12889-020-10145-1. DOI: https://doi.org/10.1186/s12889-020-10145-1

Mrityunjaya M, Pavithra V, Neelam R, et al. Immune-Boosting, Antioxidant and Anti-inflammatory Food Supplements Targeting Pathogenesis of COVID-19. Front Immunol. 2020; 11:2337; DOI: https://doi.org/10.3389/fimmu.2020.570122

doi: 10.3389/FIMMU.2020.570122/BIBTEX.

American Pharmacist Association. APhA COVID-19 Resources: Know the Facts_Pharmacists’ Guide to Coronavirus | American Pharmacists Association. 2021. Available from:

https://www.pharmacist.com/coronavirus.

Sousa Pinto G, Hung M, Okoya F, et al. FIP’s response to the COVID-19 pandemic: Global pharmacy rises to the challenge. Res Soc Adm Pharm. 2021; 17(1):1929; doi: 10.1016/J.SAPHARM.2020.07.004. DOI: https://doi.org/10.1016/j.sapharm.2020.07.004

Iacobucci G. Covid-19: Allow pharmacists to dispense controlled drugs without prescription, urge specialists. n.d.; doi: 10.1136/bmj.m1868. DOI: https://doi.org/10.1136/bmj.m1868

Haddadin RN, Alsous M, Wazaify M, et al. Evaluation of antibiotic dispensing practice in community pharmacies in Jordan: A cross sectional study. PLoS One. 2019; 14(4); doi: 10.1371/journal.pone.0216115. DOI: https://doi.org/10.1371/journal.pone.0216115

Alsous M, Elayeh E, Abdel Jalil M, et al. Evaluation of Self-Medication Practice among Pharmacy Students in Jordan. Jordan j. pharm. sci. 2018; 11(1):15–24.

Matalqah L, Albals D, Radaideh K, et al. Knowledge, Attitudes and Practice toward Antibiotic Use among Under and PostGraduate Students at Yarmouk University in Jordan: A Descriptive Study. Jordan j. pharm. sci. 2022; 15(3):378–389. DOI: https://doi.org/10.35516/jjps.v15i3.411

Elayeh E, Akour A, Haddadin RN. Prevalence and predictors of self-medication drugs to prevent or treat COVID-19: Experience from a Middle Eastern country. Int J Clin Pract. 2021; 75(11); doi: 10.1111/IJCP.14860. DOI: https://doi.org/10.1111/ijcp.14860

Al-Azzam S, Mhaidat NM, Banat HA, et al. An Assessment of the Impact of Coronavirus Disease (COVID-19) Pandemic on National Antimicrobial Consumption in Jordan. Antibiot. 2021; 10(6):690; doi: 10.3390/ANTIBIOTICS10060690. DOI: https://doi.org/10.3390/antibiotics10060690

Brown JD, Vouri SM, Manini TM. Survey-reported medication changes among older adults during the SARS-CoV-2 (COVID-19) pandemic. Res Soc Adm Pharm. 2020; doi: 10.1016/j.sapharm.2020.11.005. DOI: https://doi.org/10.1016/j.sapharm.2020.11.005

Saleh EA, Haddadin RN, Saleh B, et al. Changes in drug demand when a pandemic coincides with other outbreaks in a war zone country: a cross-sectional pilot study. J Pharm Policy Pract. 2022; 15(1):89; doi: 10.1186/S40545-022-00487-Z. DOI: https://doi.org/10.1186/s40545-022-00487-z

Reuben RC, Danladi MMA, Saleh DA, et al. Knowledge, Attitudes and Practices Towards COVID-19: An Epidemiological Survey in North-Central Nigeria. J Community Health. 2021; 46(3):457–470;

doi: 10.1007/s10900-020-00881-1. DOI: https://doi.org/10.1007/s10900-020-00881-1

Elayeh E, Aleidi SM, Ya’acoub R, et al. Before and after case reporting: A comparison of the knowledge, attitude and practices of the Jordanian population towards COVID-19. PLoS One. 2020; 15(10 October); doi: 10.1371/journal.pone.0240780. DOI: https://doi.org/10.1371/journal.pone.0240780

Lino M, Di Giuseppe G, Albano L, et al. Parental knowledge, attitudes and behaviours towards influenza A/H1N1 in Italy. Eur J Public Health. 2012; 22(4):568–572; doi: 10.1093/EURPUB/CKR115. DOI: https://doi.org/10.1093/eurpub/ckr115

Jordan-MOH. اThe Protocol of Diagnosis and Treatment of COVID-19 Patients, Issued by the Ministry of Health (Arabic). 2020. Available at: https://corona.moh.gov.jo/ar/MediaCenter/1408 [Last accessed: 12/9/2021].

Wegbom AI, Edet CK, Raimi O, et al. Self-Medication Practices and Associated Factors in the Prevention and/or Treatment of COVID-19 Virus: A Population-Based Survey in Nigeria. Front Public Heal. 2021; 9:606801; doi: 10.3389/FPUBH.2021.606801/FULL. DOI: https://doi.org/10.3389/fpubh.2021.606801

Ghaith A, Echchad M, AlHaman F, et al. Assessing the Influence of the COVID-19 Pandemic on the Purchasing Intention of Vitamins in Kuwait using the Theory of Planned Behavior. Jordan j. pharm. sci 2023; 16(3):565–577. DOI: https://doi.org/10.35516/jjps.v16i3.1611

Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020; 56(1):105949; doi: 10.1016/J.IJANTIMICAG.2020.105949. DOI: https://doi.org/10.1016/j.ijantimicag.2020.105949

Karampela I, Dalamaga M. Could Respiratory Fluoroquinolones, Levofloxacin and Moxifloxacin, Prove to be Beneficial as an Adjunct Treatment in COVID-19? Arch Med Res. 2020; 51(7):741–742; doi: 10.1016/J.ARCMED.2020.06.004. DOI: https://doi.org/10.1016/j.arcmed.2020.06.004

Ahmad S, Babar MS, Essar MY, et al. Infodemic, self-medication and stockpiling: a worrying combination. East Mediterr Health J. 2021; 27(5):438–440; doi: 10.26719/EMHJ.21.010. DOI: https://doi.org/10.26719/emhj.21.010

Quispe-cañari JF, Fidel-rosales E, Manrique D, et al. Prevalence of self-medication during the COVID-19 pandemic in Peru. SSRN 2020. DOI: https://doi.org/10.2139/ssrn.3688880

Nasir M, Chowdhury ASMS, Zahan T. Self-medication during COVID-19 outbreak: a cross sectional online survey in Dhaka city. Int J Basic Clin Pharmacol. 2020; 9(9):1325;

doi: 10.18203/2319-2003.ijbcp20203522. DOI: https://doi.org/10.18203/2319-2003.ijbcp20203522

CDC. Treatments Your Healthcare Provider Might Recommend If You Are Sick | CDC. 2021. Available at: https://www.cdc.gov/coronavirus/2019-ncov/your-health/treatments-for-severe-illness.html [Last accessed: 12/9/2021].

Godino C, Scotti A, Maugeri N, et al. Antithrombotic therapy in patients with COVID-19? -Rationale and Evidence-. Int J Cardiol. 2021; 324:261; doi: 10.1016/J.IJCARD.2020.09.064. DOI: https://doi.org/10.1016/j.ijcard.2020.09.064

NIH. Antithrombotic Therapy | COVID-19 Treatment Guidelines. 2021. Available at:

https://www.covid19treatmentguidelines.nih.gov/therapies/antithrombotic-therapy/ [Last accessed: 12/9/2021].

Mak IWC, Chu CM, Pan PC, et al. Long-term psychiatric morbidities among SARS survivors. Gen Hosp Psychiatry. 2009; 31(4):318–326;

doi: 10.1016/J.GENHOSPPSYCH.2009.03.001. DOI: https://doi.org/10.1016/j.genhosppsych.2009.03.001

CDC. Coping with Stress. 2021. Available at: https://www.cdc.gov/mentalhealth/stress-coping/cope-with-stress/index.html [Last accessed: 12/9/2021].

WHO. #HealthyAtHome - Mental Health. 2021. Available at:

https://www.who.int/campaigns/connecting-the-world-to-combat-coronavirus/healthyathome/healthyathome---mental-health [Last accessed: 12/9/2021].

Alnazly E, Khraisat OM, Al-Bashaireh AM, et al. Anxiety, depression, stress, fear and social support during COVID-19 pandemic among Jordanian healthcare workers. PLoS One. 2021; 16(3):e0247679; doi: 10.1371/JOURNAL.PONE.0247679. DOI: https://doi.org/10.1371/journal.pone.0247679

Feinmann J. How covid-19 revealed the scandal of medical oxygen supplies worldwide. BMJ. 2021; 373; doi: 10.1136/BMJ.N1166. DOI: https://doi.org/10.1136/bmj.n1166

UNICEF. Oxygen Concentrators During COVID-19 | UNICEF China. 2021. Available at: https://www.unicef.cn/en/stories/oxygen-concentrators-during-covid-19 [Last accessed: 12/9/2021].

Downloads

Published

2024-03-19

How to Cite

Elayeh, E. R., Haddadin, R. N., Dawud, R. J., Alsinjlawi, H. o., & Zidan, R. k. (2024). Navigating Changes in Patient Drug and Non-Drug Item Demands in Community Pharmacies Amidst the COVID-19 Pandemic: Changes in drug demand during COVID19. Jordan Journal of Pharmaceutical Sciences, 17(1), 31–44. https://doi.org/10.35516/jjps.v17i1.1426

Issue

Section

Articles